{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:12:20Z","timestamp":1788455540590,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH 1126801C"],"award-info":[{"award-number":["TCVGH 1126801C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["1126801C"],"award-info":[{"award-number":["1126801C"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2314-B-075A-001-MY3"],"award-info":[{"award-number":["NSTC 111-2314-B-075A-001-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-075A-001-MY3"],"award-info":[{"award-number":["111-2314-B-075A-001-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.anai.2024.11.016","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T12:27:19Z","timestamp":1732796839000},"page":"333-340.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-3533","authenticated-orcid":false,"given":"Teng-Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Sheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Kuei","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10247","key":"10.1016\/j.anai.2024.11.016_bib0001","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anai.2024.11.016_bib0002","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2024.11.016_bib0003","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality: an update from the global burden of disease study 2013","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.03.017","article-title":"Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis","volume":"79","author":"R\u00f8nnstad","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2024.11.016_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/DER.0000000000000418","article-title":"Atopic dermatitis and hospitalization for mental health disorders in the United States","volume":"30","author":"Hsu","year":"2019","journal-title":"Dermatitis"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0006","first-page":"93","article-title":"Atopic dermatitis and psychosocial comorbidities","volume":"18","author":"Kage","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"10.1016\/j.anai.2024.11.016_bib0007","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2018.08.005","article-title":"Sleep disorders and atopic dermatitis: a 2-way street?","volume":"142","author":"Chang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaad.2022.06.008","article-title":"Sleep impairment in patients with chronic inflammatory skin diseases: a review of mechanisms and management","volume":"88","author":"Duan","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0009","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","article-title":"Mental health comorbidity in patients with atopic dermatitis","volume":"131","author":"Yaghmaie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.11.016_bib0010","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaip.2020.12.007","article-title":"Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies","volume":"9","author":"Bawany","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2024.11.016_bib0011","article-title":"Is there an association between inflammatory\/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample","volume":"22","author":"Caldiroli","year":"2022","journal-title":"Brain Behav Immun Health"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0012","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.2007.01128.x","article-title":"Elevated cytokine expression in the orbitofrontal cortex of victims of suicide","volume":"117","author":"Tonelli","year":"2008","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.anai.2024.11.016_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/neu.2020.23","article-title":"Interleukin-4 and anxiety in adults with atopic dermatitis","volume":"32","author":"Gray","year":"2020","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/imm.12525","article-title":"Chrono-immunology: progress and challenges in understanding links between the circadian and immune systems","volume":"146","author":"Geiger","year":"2015","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0015","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1542\/peds.2014-0376","article-title":"Atopic dermatitis, melatonin, and sleep disturbance","volume":"134","author":"Chang","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaad.2018.08.063","article-title":"Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis","volume":"80","author":"Patel","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"10.1016\/j.anai.2024.11.016_bib0017","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2024.11.016_bib0018","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/09546634.2019.1612836","article-title":"Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2","volume":"31","author":"Cork","year":"2020","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.anai.2024.11.016_bib0019","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236\u2009379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2024.05.029","article-title":"Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: a population-based cohort study","volume":"91","author":"Lin","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2024.11.016_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jad.2016.06.012","article-title":"Risk of developing major depression and bipolar disorder among adolescents with atopic diseases: a nationwide longitudinal study in Taiwan","volume":"203","author":"Wei","year":"2016","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0022","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2022.04.061","article-title":"Longitudinal course and predictors of depressive symptoms in atopic dermatitis","volume":"87","author":"Chatrath","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"436","key":"10.1016\/j.anai.2024.11.016_bib0023","first-page":"1","article-title":"Sleep difficulties in adults: United States, 2020","author":"Adjaye-Gbewonyo","year":"2022","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.anai.2024.11.016_bib0024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2016.12.001","article-title":"Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations","volume":"82","author":"Manja","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.anai.2024.11.016_bib0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","article-title":"Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research","volume":"47","author":"Moride","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.anai.2024.11.016_bib0026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13712","article-title":"Inflammation in psychiatric disorders: what comes first?","volume":"1437","author":"Bauer","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.anai.2024.11.016_bib0027","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2024.11.016_bib0028","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2024.11.016_bib0029","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/exd.14786","article-title":"Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with dupilumab: data up to 3 years","volume":"32","author":"Miniotti","year":"2023","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2024.11.016_bib0030","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1002\/ski2.294","article-title":"Risk of developing psychiatric disease among adult patients with skin disease: a 9-year national register follow-up study in Norway","volume":"3","author":"Balieva","year":"2023","journal-title":"Skin Health Dis"},{"issue":"10","key":"10.1016\/j.anai.2024.11.016_bib0031","doi-asserted-by":"crossref","first-page":"adv00573","DOI":"10.2340\/00015555-3886","article-title":"Rapid and sustained effect of dupilumab on work productivity in patients with difficult-to-treat atopic dermatitis: results from the Dutch BioDay registry","volume":"101","author":"Ari\u00ebns","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0032","doi-asserted-by":"crossref","first-page":"e15022","DOI":"10.1111\/exd.15022","article-title":"Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis","volume":"33","author":"Sakurai","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.anai.2024.11.016_bib0033","series-title":"Age of Onset of Mental Disorders","first-page":"217","article-title":"The age of onset of attention-deficit hyperactivity disorder","author":"Coghill","year":"2019"},{"issue":"4","key":"10.1016\/j.anai.2024.11.016_bib0034","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaad.2023.01.025","article-title":"Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder: a retrospective cohort study","volume":"88","author":"Yildirim","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2024.11.016_bib0035","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1111\/jdv.16865","article-title":"Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials","volume":"35","author":"Beck","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.anai.2024.11.016_bib0036","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/bjd\/ljad284","article-title":"Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study","volume":"189","author":"Merola","year":"2023","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0037","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/psyg.12319","article-title":"Sleep disorders in the elderly: a growing challenge","volume":"18","author":"Gulia","year":"2018","journal-title":"Psychogeriatrics"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cger.2021.04.001","article-title":"Normal and abnormal sleep in the elderly","volume":"37","author":"Feinsilver","year":"2021","journal-title":"Clin Geriatr Med"},{"issue":"8","key":"10.1016\/j.anai.2024.11.016_bib0039","first-page":"804","article-title":"Efficacy of dupilumab in different racial subgroups of adults with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials","volume":"18","author":"Alexis","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.anai.2024.11.016_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jdin.2022.09.006","article-title":"Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types","volume":"10","author":"Bosma","year":"2022","journal-title":"JAAD Int"},{"issue":"1","key":"10.1016\/j.anai.2024.11.016_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"8-9","key":"10.1016\/j.anai.2024.11.016_bib0042","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jamia\/ocz113","article-title":"Challenges with quality of race and ethnicity data in observational databases","volume":"26","author":"Polubriaginof","year":"2019","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"10.1016\/j.anai.2024.11.016_bib0043","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.amjsurg.2023.05.011","article-title":"The accuracy of race & ethnicity data in US based healthcare databases: a systematic review","volume":"226","author":"Johnson","year":"2023","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.anai.2024.11.016_bib0044","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624017071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624017071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:23:28Z","timestamp":1778588608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624017071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1081120624017071"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.11.016","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}